title: Immunoglobulin therapy.
abstract: Immunoglobulin is an expensive blood product of potentially limited supply used in a wide variety of medical conditions, across a number of specialties. Historically, immunoglobulin has been associated with transmission of blood borne infection (eg hepatitis C). Immunoglobulin use needs to be carefully considered, appropriately prescribed and recorded. The Department of Health, in conjunction with relevant stakeholders, has established a demand management programme to secure immunoglobulin supplies for patients most in need of treatment and to limit use for indications where evidence is lacking.
authors.affiliation: North Bristol NHS Trust, Bristol, UK.
authors.forename: Sarah Louise
authors.initials: SL
authors.lastname: Johnston
authors.affiliation: Medical Data Solutions and Services, Manchester UK.
authors.forename: Rob
authors.initials: R
authors.lastname: Hollingsworth
mesh_terms: D001987:Bronchiectasis / Q000628:therapy; D006801:Humans; D007116:Immunization, Passive; D007153:Immunologic Deficiency Syndromes / Q000628:therapy; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000628:therapy
keywords: Blood product; demand management; immunoglobulin; immunomodulatory; replacement